Intensity Therapeutics, Inc. Financial Overview
Intensity Therapeutics, Inc.'s market cap is currently $26.24M. The company's EPS TTM is $-0.06; its P/E ratio is -0.65; Intensity Therapeutics, Inc. is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
